Lacosamide Arrow (Lacosamide)

Lacosamide is an antiepileptic drug that targets neuronal hyperexcitability in seizure disorders.

• Partial‑onset seizures: reduces the frequency and severity of focal seizures.
• Adjunctive therapy for epilepsy: helps achieve better overall seizure control when added to existing regimens.
• Focal seizures: improves seizure management in patients with focal onset epilepsy.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing repetitive neuronal firing. By selectively targeting the slow inactivation phase, it reduces neuronal excitability without affecting normal rapid channel activity, contributing to seizure control in epileptic patients.

Lacosamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: mild to moderate stomach upset.
• Fatigue: increased tiredness or lack of energy.
• Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects

• Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention.
• Cardiac arrhythmia: abnormal heart rhythm, especially in patients with pre‑existing conduction disorders.
• Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.
• Severe hepatic dysfunction: signs of liver injury such as jaundice or elevated enzymes.

Before initiating Lacosamide therapy, several safety considerations should be reviewed.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: use with caution and observe liver enzymes.
• Cardiac conduction disorders: obtain baseline ECG and monitor for PR interval changes.
• Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional.
• Concomitant antiepileptic drugs: assess for additive CNS effects and adjust dosing accordingly.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may markedly reduce lacosamide plasma levels.
• Co‑administration with other sodium‑channel blockers (e.g., lamotrigine): may increase central nervous system depression.
• QT‑prolonging agents: combined use may heighten the risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Other antiepileptic drugs: dose adjustments may be required to maintain seizure control.
• Alcohol: may enhance dizziness and sedation.
• Hormonal contraceptives: lacosamide may reduce contraceptive effectiveness; consider alternative methods.